Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patient preferences in choosing anti-TNF therapies-R1.

Literature DB >> 17085468

Patient preferences in choosing anti-TNF therapies-R1.

E L Williams, C J Edwards.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2006 PMID： 17085468 DOI： 10.1093/rheumatology/kel369

Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580

Keyword Cloud
Cited

× No keyword cloud information.

31 in total

Review 1. Biologic agents for IBD: practical insights.

Authors: Silvio Danese; Lucine Vuitton; Laurent Peyrin-Biroulet
Journal: Nat Rev Gastroenterol Hepatol Date: 2015-08-18 Impact factor: 46.802

Review 2. Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.

Authors: Rieke Alten; Yoorim An; Dong-Hyeon Kim; SangWook Yoon; Laurent Peyrin-Biroulet
Journal: Clin Drug Investig Date: 2022-06-03 Impact factor: 2.859

3. What factors determine patients' preference for tumour necrosis factor inhibitors in ankylosing spondylitis?

Authors: Dessy W Fajri; Caroline A Brand; Shyamali C Dharmage; Belinda J Martin; Russell R C Buchanan; Lionel Schachna
Journal: Clin Rheumatol Date: 2009-02-14 Impact factor: 2.980

4. Considering patient preferences when selecting anti-tumor necrosis factor therapeutic options.

Authors: Gosia Sylwestrzak; Jinan Liu; Judith J Stephenson; Alexander P Ruggieri; Andrea DeVries
Journal: Am Health Drug Benefits Date: 2014-04

5. Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review.

Authors: Kelly L Stoner; Helena Harder; Lesley J Fallowfield; Valerie A Jenkins
Journal: Patient Date: 2014-07-12 Impact factor: 3.883

6. How do patients with inflammatory bowel disease want their biological therapy administered?

Authors: Patrick B Allen; Hannah Lindsay; Tony C K Tham
Journal: BMC Gastroenterol Date: 2010-01-10 Impact factor: 3.067

7. Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis.

Authors: U Müller-Ladner; R M Flipo; P Vincendon; Y Brault; D Kielar
Journal: Z Rheumatol Date: 2012-12 Impact factor: 1.372